In an orthotopic breast cancer model, inhibition of PHD2 by an HIF-hydroxylase inhibitor DMOG (dimethyloxalylglycine) reduces primary tumor stiffness and metastases of tumor cells to distant organs. Here, EGLN1 is linked to neoplasm.